• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. LEAD MODEL 304

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. LEAD MODEL 304 Back to Search Results
Model Number 304-30
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Partial Hearing Loss (4472); Skin Infection (4544)
Date of Event 06/15/2017
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that by the patient that following a lead revision procedure, he has experienced hearing loss in his left ear.No other relevant information has been received to date.No known surgical intervention has occurred to date.
 
Additional Manufacturer Narrative
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any defects¿ or ;malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
 
Event or Problem Description
Additional information was received that the patient presented with an infection at the electrode site following the lead revision procedure.Device history records were reviewed for the lead.The device passed all functional specifications and quality tests and were sterilized prior to distribution.No other relevant information has been received to date.
 
Additional Manufacturer Narrative
H3.Device evaluated by mfr? code 81 - device evaluation is not necessary because the reported event has been determined as not related to the functionality or delivery of therapy of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 304
Common Device Name
LEAD
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
cindy scott
100 cyberonics blvd
suite 600
houston, TX 77058
2816672681
MDR Report Key21273913
Report Number1644487-2025-00082
Device Sequence Number8080628
Product Code LYJ
UDI-Device Identifier05425025750153
UDI-Public05425025750153
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P970003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/28/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date01/25/2021
Device Model Number304-30
Device Lot Number5171
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/06/2025
Supplement Date Received by Manufacturer02/04/2025
Initial Report FDA Received Date01/30/2025
Supplement Report FDA Received Date02/28/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/30/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age41 YR
Patient SexMale
-
-